Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Three hemp varieties received approval from Health Canada

Arcadia Biosciences' three GoodHemp varieties have earned approval from Health Canada for their consistency and compliance. This approval follows the recent certification of GoodHemp seed varieties by the Association of Official Seed Certifying Agencies (AOSCA) and is the final step to enable hemp seed sales in Canada. GoodHemp seed varieties and genetics are distributed in Canada by Tritium 3H, Inc. (T3H), which specializes in hemp field testing, certified seed production, commercialization and distribution of industrial hemp varieties. "The approval from Health Canada broadens the geographic opportunities for GoodHemp and enables growers to access seeds through Tritium for the 2021 growing season. “The Health Canada approval demonstrates the stability and compliance of our cultivars,” said Arcadia CEO Matt Plavan. “We are happy to report we have already shipped the first GoodHemp seed order to Tritium 3H to bring our CBD-dominant, short-day varieties to Canada’s industrial hemp growers for the 2021 planting season.”

“We’re pleased to partner with Arcadia in bringing these high CBD, early maturing feminized hybrids to Canada,” said Jayme Hunter, Tritium 3H CEO. “These GoodHemp varieties performed well in our 2020 field trials with excellent yield, uniformity and quality; they are hybrids with excellent performance potential in Canada’s hemp growing regions.”

GoodHemp is Arcadia’s commercial portfolio of genetically superior hemp seeds, transplants, and extracts introduced in 2019. Since then, Arcadia has been rapid-prototyping novel non-GMO hemp varieties that target quality and performance characteristics highly desired by growers to overcome their greatest challenges. GoodHemp varieties have been field-tested extensively in regional and national trials by the T3H and Arcadia teams.

For more information:
Arcadia Biosciences
Arcadia Biosciences
T: (530) 756-7077
F: (530) 756-7027
info@arcadiabio.com   
arcadiabio.com    

Publication date: